Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MRNS will rise by +12.87% over the next 2 Weeks and hit $0.62 by Tuesday, February 25, 2025. In that time frame, MRNS's share price is expected to range between $0.53 and $0.71.
BearishAverageBullishMRNS shares remained flat 0 in Monday, February 10, 2025's trading session, starting and closing at a previous close of $0.55 to move at $0.55. The stock demonstrated notable intraday movement (see MRNS's key stats for a full breakdown), fluctuating between $0.55 and $0.55, a +0.15% trading range. While recent weeks have seen some volatility, MRNS has managed to secure a +1.25% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 1.1M shares changing hands, 1.42K more than the previous session. This amounted to $606.54K in total market activity.
Will MRNS Continue Its Upward Trend?
According to analyst ratings and projections for MRNS, Marinus Pharmaceuticals, Inc. shares are anticipated to increase by +28.90%, potentially reaching $0.77 per share by February 25, 2025. Short-term technical indicators currently suggest a neutral sentiment for MRNS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the MRNS stock forecast, now is a good time to buy MRNS stock because its current trading price is -18.61% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MRNS covering social and institutional perspectives.
MRNS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MRNS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.92% to 77.84%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 44.58%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.20%, maintains a neutral outlook for the long term. Insights into MRNS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Marinus Pharmaceuticals Short-Term Forecasts
MRNS Forecast For Next 5 Days
Our algorithm anticipates Marinus Pharmaceuticals (MRNS) stock could hit $0.53 by Mar 13, 2025. This represents a -3.80% rise from today's price, following a +0.62% change over the past five days.
MRNS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Marinus Pharmaceuticals, Inc. (MRNS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.52, which would mean a -5.45% decrease from the current price of $0.55. Projections for this period range from a high of $0.61 to a low of $0.41.
MRNS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Marinus Pharmaceuticals's price over the next three months point to a drop. MRNS stock is expected to peak at $0.00 on Feb 11, 2026 before potentially dipping to $0.00 on Feb 11, 2026. On average, MRNS is likely to trade around $0.35 in the coming 90 days.
Marinus Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Marinus Pharmaceuticals (MRNS) is expected to trade between $0.00 and $2.73 throughout 2025. This would result in an average price of $1.10, potentially offering investors a +100.00% return from current levels.
Marinus Pharmaceuticals, Inc. Monthly Forecast 2025–2026
March 2025
According to our latest forecast models, Marinus Pharmaceuticals, Inc. (MRNS) is positioned to show a strong performance in March 2025. The price is predicted to move between $2.05 and $2.73, settling at an average of $2.55. This could translate to a +363.64% gain.
April 2025
Based on current market signals, Marinus Pharmaceuticals, Inc. is projected to trend april 2025. We forecast a trading range from $1.01 to $2.18, with a likely average price of $1.53. Investors could expect a potential return of +178.18%.
May 2025
Our predictive algorithms indicate Marinus Pharmaceuticals, Inc. stock may see a shift in May 2025. The expected range spans $0.94–$1.29, with an average target of $1.26. This represents a positive outlook and a possible gain of +129.09%.
June 2025
Analyzing established trends, Marinus Pharmaceuticals, Inc. looks set to move in June 2025. Projections place the stock between $0.55 and $1.27, averaging around $1.18. This suggests a +114.55% gain from current levels.
July 2025
Market indicators suggest Marinus Pharmaceuticals, Inc. could experience notable changes during July 2025. Prices could fluctuate within $0.16 to $1.01, with a midpoint forecast of $1.23. The stock might deliver a +123.64% gain.
August 2025
Forecasting for August 2025, models estimate that Marinus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.83, averaging $1.12. This signals a positive trajectory with potential returns around +103.64%.
September 2025
According to our latest forecast models, Marinus Pharmaceuticals, Inc. (MRNS) is positioned to show a strong performance in September 2025. The price is predicted to move between $0.00 and $0.26, settling at an average of $0.89. This could translate to a +61.82% gain.
October 2025
Based on current market signals, Marinus Pharmaceuticals, Inc. is projected to trend october 2025. We forecast a trading range from $0.00 to $0.00, with a likely average price of $0.80. Investors could expect a potential return of +45.45%.
November 2025
Our predictive algorithms indicate Marinus Pharmaceuticals, Inc. stock may see a shift in November 2025. The expected range spans $0.00–$0.00, with an average target of $0.40. This represents a cautious outlook and a possible loss of -27.27%.
December 2025
Analyzing established trends, Marinus Pharmaceuticals, Inc. looks set to move in December 2025. Projections place the stock between $0.00 and $0.00, averaging around $0.40. This suggests a -27.27% loss from current levels.
January 2026
Market indicators suggest Marinus Pharmaceuticals, Inc. could experience notable changes during January 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.35. The stock might deliver a -36.36% loss.
February 2026
Forecasting for February 2026, models estimate that Marinus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.26. This signals a cautious trajectory with potential returns around -52.73%.
MRNS's history of dividends and stock splits also plays a role in long-term investor confidence.